Inmunobiología linfocitaria
Universitat de Barcelona
Barcelona, EspañaUniversitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (24)
2024
-
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo
Science translational medicine, Vol. 16, Núm. 734, pp. eadg7962
-
Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet
Pharmacological Research, Vol. 200
2023
-
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
Kidney360, Vol. 4, Núm. 5, pp. 659-672
-
Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis
Gastroenterologia y Hepatologia
-
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895
-
Thrombotic microangiopathy in patients with malignant hypertension
Nephrology Dialysis Transplantation, Vol. 38, Núm. 5, pp. 1217-1226
2022
-
C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies
Nephrology Dialysis Transplantation, Vol. 37, Núm. 11, pp. 2128-2137
-
Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain
European Journal of Health Economics, Vol. 23, Núm. 3, pp. 551-558
-
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy
Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746
-
Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis
Journal of Hepatology, Vol. 77, Núm. 1, pp. 15-28
-
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280
-
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers
Cancer immunology research, Vol. 10, Núm. 4, pp. 498-511
2021
-
Advanced preclinical models for evaluation of drug-induced liver injury – consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]
Journal of Hepatology, Vol. 75, Núm. 4, pp. 935-959
-
Transcriptomic profiling of the liver sinusoidal endothelium during cirrhosis reveals stage-specific secretory signature
Cancers, Vol. 13, Núm. 11
-
Validation of a Histologic Scoring Index for C3 Glomerulopathy
American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1
2020
-
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Science, Vol. 370, Núm. 6515
-
Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies
Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 10, pp. 3342-3347
-
Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 9, pp. 438-443
-
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Science, Vol. 370, Núm. 6515
-
Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease
Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298